QALY maximisation and people's preferences: a methodological review of the literature

Health Economics
P DolanAlan Williams

Abstract

In cost-utility analysis, the numbers of quality-adjusted life years (QALYs) gained are aggregated according to the sum-ranking (or QALY maximisation) rule. This requires that the social value from health improvements is a simple product of gains in quality of life, length of life and the number of persons treated. The results from a systematic review of the literature suggest that QALY maximisation is descriptively flawed. Rather than being linear in quality and length of life, it would seem that social value diminishes in marginal increments of both. And rather than being neutral to the characteristics of people other than their propensity to generate QALYs, the social value of a health improvement seems to be higher if the person has worse lifetime health prospects and higher if that person has dependents. In addition, there is a desire to reduce inequalities in health. However, there are some uncertainties surrounding the results, particularly in relation to what might be affecting the responses, and there is the need for more studies of the general public that attempt to highlight the relative importance of various key factors.

References

Dec 1, 1991·Journal of Medical Ethics·J Harris
Jan 1, 1989·Social Science & Medicine·M C CharnyS C Farrow
Jul 1, 1995·Medical Decision Making : an International Journal of the Society for Medical Decision Making·E Nord
Jan 1, 1994·Health Economics·J A Olsen
Jul 1, 1993·Social Science & Medicine·J J BusschbachF T de Charro
Mar 16, 1996·BMJ : British Medical Journal·A Bowling
May 2, 1996·The New England Journal of Medicine·P A UbelD A Asch
Apr 1, 1996·Social Science & Medicine·P A Ubel, G Loewenstein
Jul 1, 1996·Medical Decision Making : an International Journal of the Society for Medical Decision Making·P A Ubel, G Loewenstein
Jan 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·A M Holmes
May 5, 1998·Medical Decision Making : an International Journal of the Society for Medical Decision Making·P A UbelD A Asch
May 5, 1998·Medical Decision Making : an International Journal of the Society for Medical Decision Making·B R Luce
Jul 17, 1998·BMJ : British Medical Journal·J NeubergerM Speed
Dec 9, 1998·Health Economics·L Lindholm, M Rosén
Feb 27, 1999·Social Science & Medicine·A Tsuchiya
Apr 9, 1991·Journal of Health Economics·A Wagstaff
Nov 4, 1993·Journal of Health Economics·A J Culyer, A Wagstaff
Jul 7, 1995·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·G MooneyV Wiseman
May 7, 1996·Journal of Health Economics·M Johannesson, U Gerdtham
Apr 7, 1996·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·E NordP Singer
Apr 8, 1995·Journal of Aging and Health·L B Kuder, P W Roeder
Sep 4, 1997·Journal of Health Economics·M Johannesson, P O Johansson
Dec 8, 1997·Journal of Health Economics·P Dolan
Nov 3, 1997·Journal of Health Economics·C J Murray, A K Acharya
Sep 4, 1997·Journal of Health Services Research & Policy·N ChoudhryC D Naylor
Jul 9, 1999·Journal of Epidemiology and Community Health·L LindholmM Emmelin
Sep 2, 1999·Health Economics·F Andersson, C H Lyttkens
Dec 11, 1999·Health Economics·J M Abellan-Perpiñan, J L Pinto-Prades
May 29, 2000·Health Policy·R Cookson, P Dolan
Sep 30, 2000·Journal of Health Economics·J A Olsen

❮ Previous
Next ❯

Citations

May 8, 2010·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·A SchwalmA Gerber
Apr 3, 2007·European Child & Adolescent Psychiatry·Michael Schlander
Aug 27, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·E J van de WeteringW B F Brouwer
May 10, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Koonal K ShahAllan J Wailoo
Jul 22, 2009·International Journal of Technology Assessment in Health Care·Daniëlle C M WillemsJohannes J E Hendriks
Jan 26, 2011·International Journal of Technology Assessment in Health Care·Irina CleemputMark Leys
Dec 3, 2013·International Journal of Technology Assessment in Health Care·Katarzyna KolasaMichael Lees
Jul 19, 2008·Health Economics, Policy, and Law·Paul Dolan
Feb 17, 2009·Health Economics, Policy, and Law·Richard CooksonHelen Weatherly
Jan 16, 2007·Annual Review of Public Health·Scott D GrosseAnne C Haddix
Oct 17, 2013·Cost Effectiveness and Resource Allocation : C/E·Takeru ShiroiwaShunya Ikeda
Jun 21, 2011·Orphanet Journal of Rare Diseases·Steven Simoens
Sep 1, 2006·PharmacoEconomics·Duncan Mortimer
Feb 22, 2011·Applied Health Economics and Health Policy·Afschin Gandjour
Apr 22, 2011·Applied Health Economics and Health Policy·Daniel EisenbergLisa A Prosser
Nov 15, 2011·PharmacoEconomics·Hareth Al-JanabiJoanna Coast
Apr 4, 2012·International Journal of Environmental Research and Public Health·Jeannette Winkelhage, Adele Diederich
Dec 7, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·E J van de WeteringW B F Brouwer
Aug 3, 2012·Journal of Health Organization and Management·Sarah Clark, Albert Weale
Mar 22, 2011·Disaster Medicine and Public Health Preparedness·J Jaime CaroAnn R Knebel
Jul 18, 2008·American Journal of Public Health·Sofia Gruskin, Norman Daniels
Apr 22, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Axel C Mühlbacher
Dec 18, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Afschin Gandjour
Jul 22, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Stavros Petrou
Apr 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Scott D Grosse
Dec 30, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Arthur E Attema
Apr 2, 2013·Social Science & Medicine·Betty GillBeryl Hesketh
May 24, 2012·The Hastings Center Report·Emily A Largent, Steven D Pearson
Jun 29, 2012·Social Science & Medicine·Duncan Mortimer, Stuart Peacock

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.